Show simple item record

HOX transcription factors are potential targets and markers in malignant mesothelioma

dc.contributor.authorMorgan, Richard*
dc.contributor.authorSimpson, G.R.*
dc.contributor.authorGray, S.*
dc.contributor.authorGillett, C.*
dc.contributor.authorTabi, Z.*
dc.contributor.authorSpicer, J.*
dc.contributor.authorHarrington, K.J.*
dc.contributor.authorPandha, H.S.*
dc.date.accessioned2016-07-07T14:28:21Z
dc.date.available2016-07-07T14:28:21Z
dc.date.issued2016
dc.identifier.citationMorgan R, Simpson G, Gray S, et al (2016) HOX transcription factors are potential targets and markers in malignant mesothelioma. BMC Cancer. 16(1): Article 85.
dc.identifier.urihttp://hdl.handle.net/10454/8603
dc.descriptionYes
dc.description.abstractBackground The HOX genes are a family of homeodomain-containing transcription factors that determine cellular identity during development and which are dys-regulated in some cancers. In this study we examined the expression and oncogenic function of HOX genes in mesothelioma, a cancer arising from the pleura or peritoneum which is associated with exposure to asbestos. Methods We tested the sensitivity of the mesothelioma-derived lines MSTO-211H, NCI-H28, NCI-H2052, and NCI-H226 to HXR9, a peptide antagonist of HOX protein binding to its PBX co-factor. Apoptosis was measured using a FACS-based assay with Annexin, and HOX gene expression profiles were established using RT-QPCR on RNA extracted from cell lines and primary mesotheliomas. The in vivo efficacy of HXR9 was tested in a mouse MSTO-211H flank tumor xenograft model. Results We show that HOX genes are significantly dysregulated in malignant mesothelioma. Targeting HOX genes with HXR9 caused apoptotic cell death in all of the mesothelioma-derived cell lines, and prevented the growth of mesothelioma tumors in a mouse xenograft model. Furthermore, the sensitivity of these lines to HXR9 correlated with the relative expression of HOX genes that have either an oncogenic or tumor suppressive function in cancer. The analysis of HOX expression in primary mesothelioma tumors indicated that these cells could also be sensitive to the disruption of HOX activity by HXR9, and that the expression of HOXB4 is strongly associated with overall survival. Conclusion HOX genes are a potential therapeutic target in mesothelioma, and HOXB4 expression correlates with overall survival.
dc.description.sponsorshipThe authors gratefully acknowledge the support of the British Lung Foundation, grant number ICAPPG10-1. KJH acknowledges support from the ICR/RM NIHR Biomedical Research Centre.
dc.language.isoen
dc.rights© Morgan et al. 2016. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
dc.subjectMesothelioma
dc.subjectHOX genes
dc.subjectHXR9
dc.subjectHOXB4
dc.subjectOverall survival
dc.titleHOX transcription factors are potential targets and markers in malignant mesothelioma
dc.status.refereedYes
dc.date.Accepted2016
dc.date.application2016-02-11
dc.typeArticle
dc.type.versionAccepted manuscript
dc.identifier.doihttps://doi.org/10.1186/s12885-016-2106-7
dc.rights.licenseCC-BY
refterms.dateFOA2018-07-25T12:49:17Z
dc.openaccess.statusopenAccess


Item file(s)

Thumbnail
Name:
Morgan_BMC_Cancer.pdf
Size:
557.5Kb
Format:
PDF
Download

This item appears in the following Collection(s)

Show simple item record